Strategic Acquisition QDx Pathology Services was acquired by LabGenomics USA in 2023 to expand diagnostic lab services and IVD products in the US, indicating growth-driven partnerships and potential for cross-sell of complementary diagnostics and digital pathology solutions.

Digital Pathology Opportunity Recent collaboration with Proscia in 2024 signals a move toward digital and computational pathology, creating opportunities to position AI-enabled workflow integrations, data interoperability, and scalable remote pathology services to potential customers.

Expanded Market Reach As an independent anatomical, molecular, and clinical pathology lab serving facilities across the U.S., there is potential to target mid to large health systems, ambulatory networks, and specialty clinics seeking integrated molecular diagnostics and infectious disease panels.

Growth and Visibility Recognized on the Inc. 5000 list in 2021 and operating with significant revenue, the company demonstrates credible growth and stability, which can support discussions around reliability, capacity expansion, and scalable B2B service agreements.

Public Healthcare Partnerships Past collaborations such as providing COVID-19 PCR testing for Woodcraft camps and broad infectious disease panels create entry points for public sector, education, and community health programs requiring rapid, compliant diagnostic testing and turnkey lab support.